Amgen partners with French pharmaceuticals company

Biotechnology company Amgen Inc., which has a manufacturing plant in West Greenwich, and France-based pharmaceuticals company Servier announced a collaboration agreement that allows the exchange of rights to various cardiovascular disease therapies between the two companies. More

To continue reading this article, please do one of the following.



biotechnology

Amgen partners with French pharmaceuticals company

BLOOMBERG FILE PHOTO
AMGEN INC. and French pharmaceuticals company Servier have announced a collaboration agreement.
Posted 7/9/13

THOUSAND OAKS, Calif. – Biotechnology company Amgen Inc., which has a manufacturing plant in West Greenwich, and France-based pharmaceuticals company Servier announced a collaboration agreement that allows the exchange of rights to various cardiovascular disease therapies between the two companies.

Through the collaboration Amgen has gained commercial rights in the U.S. to Servier’s oral drug treatment for chronic heart failure, ivabradine or Procoralan in the EU. The company has also gained rights to commercialize a Servier molecule that is currently in development for cardiovascular diseases.

“Amgen is pleased to enter into this collaboration with Servier to bring potential new cardiovascular treatment options to patients in both the U.S. and Europe,” Amgen’s Executive Vice President of Research and Development Dr. Sean E. Harper said in a statement. “Ivabradine, an ifinhibitor, offers a novel alternative approach for patients with elevated heart rates.”

Servier obtained rights to commercialize in Europe an activator that is being tested to treat heart failure in patients with systolic dysfunction

Amgen will make an upfront payment of $50 million to Servier. It will also make payments for future royalties for ivabradine.

“Servier is very pleased to establish a collaboration with Amgen,” said Dr. Jean-Philippe Seta, CEO of Servier, in a statement. “This is a clear recognition of the medical value of ivabradine, one of our major cardiovascular innovations, which could also benefit U.S. patients.”

No comments on this story | Add your comment
Please log in or register to add your comment
Calendar
PBN Hosted
Events

Only a few seats remain for PBN's Manufacturing Awards Dinner and Ceremony, Thursday, April 24th, at the Bryant University Bello Center. Don't hesitate. Register today!
  • Business Women
    Accomplished. Confident. Wicked Smart. Nominate women you know who deserve speci ...
  • 40 Under Forty
    It's the 10th Anniversary of 40 Under Forty, and PBN is planning a special event ...
  • Healthiest Employers
    Enrollment now open for the 2014 Healthiest Employers Program. Please take a mom ...
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News